ReviewCNS & neurological disorders drug targets2025
Parkinson's Disease: Unravelling the Medicinal Perspectives and Recent Developments of Heterocyclic Monoamine Oxidase-B Inhibitors.
Neha Rana et al.PubMed ↗Publisher ↗
No numbers read from the abstract.